Skip to content

Opening book details…

Can I read Therapeutic Effects of Atorvastatin on Doxorubicin‐induced Hepatotoxicity in Rats via Antioxidative Damage, Anti‐inflammatory, and Anti‐lipotoxicity on EtoBox?

Therapeutic Effects of Atorvastatin on Doxorubicin‐induced Hepatotoxicity in Rats via Antioxidative Damage, Anti‐inflammatory, and Anti‐lipotoxicity by Yan‐Zhao Wu; Ke‐Xin Wang; Xin‐di Ma; Chu‐Chu Wang; Nan‐Nan Chen; Chen Xiong; Jun‐Xia Li; Su‐Wen Su is a Biochemistry, Genetics and Molecular Biology article available to read on EtoBox.

What is Therapeutic Effects of Atorvastatin on Doxorubicin‐induced Hepatotoxicity in Rats via Antioxidative Damage, Anti‐inflammatory, and Anti‐lipotoxicity about?

Doxorubicin (DOX), is a high efficiency anthracycline antitumor drug. However, the clinical application of DOX is limited mainly by dose-related adverse drug reactions. Currently, the therapeutic effects of Atorvastatin (ATO) on DOX-induced hepatotoxicity were studied in vivo. The results indicated that DOX impaired hepatic function, as measured by an increased levels of liver weight index and serum concentrations of aspartate transaminase and alanine transaminase, as well as alteration of hepatic histology. In addition, DOX increased the serum levles of triglyceride (TG) and nonestesterified fatty acid. ATO prevented these changes. Mechanical analysis revealed that ATO restored the changes of malondialdehyde, reactive oxygen radical species, glutathione peroxidase and manganese superoxide dismutase. Additionally, ATO inhibited the increased expression levels of nuclear factor-kappa B and interleukin 1β, hence suppressing inflammation. Meanwhile, ATO inhibited cell apoptosis by dramatically decreasing the Bax/Bcl-2 ratio. In addition, ATO mitigated the lipidtoxicity by inhibiting the adipolysis of TG and accelerating hepatic lipid metabolism. Taken together, the results suggest ATO

Who reads Therapeutic Effects of Atorvastatin on Doxorubicin‐induced Hepatotoxicity in Rats via Antioxidative Damage, Anti‐inflammatory, and Anti‐lipotoxicity?

It is typically read by researchers, students, and practitioners in Biochemistry, Genetics and Molecular Biology.

Author
Yan‐Zhao Wu; Ke‐Xin Wang; Xin‐di Ma; Chu‐Chu Wang; Nan‐Nan Chen; Chen Xiong; Jun‐Xia Li; Su‐Wen Su
Publisher
Wiley
Published
2023
Language
EN
Field
Biochemistry, Genetics and Molecular Biology (Life Sciences)

More by Yan‐Zhao Wu; Ke‐Xin Wang; Xin‐di Ma; Chu‐Chu Wang; Nan‐Nan Chen; Chen Xiong; Jun‐Xia Li; Su‐Wen Su

Browse all works by Yan‐Zhao Wu; Ke‐Xin Wang; Xin‐di Ma; Chu‐Chu Wang; Nan‐Nan Chen; Chen Xiong; Jun‐Xia Li; Su‐Wen Su